Stephen Johnson

Array ( [id] => 6865605 [patent_doc_number] => 20030191131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Use of organic compounds' [patent_app_type] => new [patent_app_number] => 10/395525 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3391 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191131.pdf [firstpage_image] =>[orig_patent_app_number] => 10395525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6830452 [patent_doc_number] => 20030181510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Inhibition of muscle regeneration following myectomy' [patent_app_type] => new [patent_app_number] => 10/392649 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4839 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181510.pdf [firstpage_image] =>[orig_patent_app_number] => 10392649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797593 [patent_doc_number] => 20030176467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Nicotine compositions' [patent_app_type] => new [patent_app_number] => 10/389148 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5849 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176467.pdf [firstpage_image] =>[orig_patent_app_number] => 10389148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843764 [patent_doc_number] => 20030149111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Liquid formulation of metformin' [patent_app_type] => new [patent_app_number] => 10/382442 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8328 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20030149111.pdf [firstpage_image] =>[orig_patent_app_number] => 10382442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740860 [patent_doc_number] => 20030158229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Methods for treating apnea, apnea disorders, and other disorders using optically pure (-) norcisapride' [patent_app_type] => new [patent_app_number] => 10/372875 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7807 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158229.pdf [firstpage_image] =>[orig_patent_app_number] => 10372875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660249 [patent_doc_number] => 20030134893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Combination chemotherapy' [patent_app_type] => new [patent_app_number] => 10/286498 [patent_app_country] => US [patent_app_date] => 2003-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10222 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134893.pdf [firstpage_image] =>[orig_patent_app_number] => 10286498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822202 [patent_doc_number] => 20030220363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Use of propionyl L-carnitine for the preparation of a medicament capable of inducing apoptosis' [patent_app_type] => new [patent_app_number] => 10/356547 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5773 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220363.pdf [firstpage_image] =>[orig_patent_app_number] => 10356547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797444 [patent_doc_number] => 20030176318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'p53 inhibitors and therapeutic use of the same' [patent_app_type] => new [patent_app_number] => 10/352597 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10842 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176318.pdf [firstpage_image] =>[orig_patent_app_number] => 10352597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788191 [patent_doc_number] => 20030139430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Use of organic compounds' [patent_app_type] => new [patent_app_number] => 10/348716 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3080 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139430.pdf [firstpage_image] =>[orig_patent_app_number] => 10348716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145567 [patent_doc_number] => 20050119236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'CANCER TREATMENTS AND PHARMACEUTICAL COMPOSITIONS THEREFOR' [patent_app_type] => utility [patent_app_number] => 10/340945 [patent_app_country] => US [patent_app_date] => 2003-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3815 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119236.pdf [firstpage_image] =>[orig_patent_app_number] => 10340945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660243 [patent_doc_number] => 20030134887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Use of a celecoxib composition for fast pain relief' [patent_app_type] => new [patent_app_number] => 10/330946 [patent_app_country] => US [patent_app_date] => 2002-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9587 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134887.pdf [firstpage_image] =>[orig_patent_app_number] => 10330946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 931185 [patent_doc_number] => 06979689 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-27 [patent_title] => 'Compositions and methods for treating upper respiratory congestion' [patent_app_type] => utility [patent_app_number] => 10/324425 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5260 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979689.pdf [firstpage_image] =>[orig_patent_app_number] => 10324425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706864 [patent_doc_number] => 20030153598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Methods for treating Parkinson\'s disease with cholinesterase inhibitors' [patent_app_type] => new [patent_app_number] => 10/321653 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5470 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153598.pdf [firstpage_image] =>[orig_patent_app_number] => 10321653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702270 [patent_doc_number] => 20030225150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia' [patent_app_type] => new [patent_app_number] => 10/323065 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45062 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225150.pdf [firstpage_image] =>[orig_patent_app_number] => 10323065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730834 [patent_doc_number] => 20030187024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Methods and compositions for inhibition of angiogenesis' [patent_app_type] => new [patent_app_number] => 10/319389 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6416 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187024.pdf [firstpage_image] =>[orig_patent_app_number] => 10319389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856766 [patent_doc_number] => 20030130267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 10/317518 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2047 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130267.pdf [firstpage_image] =>[orig_patent_app_number] => 10317518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 968619 [patent_doc_number] => 06939893 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-06 [patent_title] => 'Method of reducing toxicity of anticancer agents' [patent_app_type] => utility [patent_app_number] => 10/315721 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3652 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/939/06939893.pdf [firstpage_image] =>[orig_patent_app_number] => 10315721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829291 [patent_doc_number] => 20030180349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Respiratory infection prevention and treatment with terpene-containing compositions' [patent_app_type] => new [patent_app_number] => 10/314613 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15658 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180349.pdf [firstpage_image] =>[orig_patent_app_number] => 10314613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865636 [patent_doc_number] => 20030191162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => '3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy' [patent_app_type] => new [patent_app_number] => 10/307483 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36908 [patent_no_of_claims] => 120 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191162.pdf [firstpage_image] =>[orig_patent_app_number] => 10307483 [rel_patent_id] =>[rel_patent_doc_number] =>)